Synapse - Dana Rathkopf

Search Within

Dana Elizabeth Rathkopf

Results (274)

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago phase 2 consortium

Journal Article

Bradley, D.; Rathkopf, D.; Dunn, R.; Stadler, W. M.; Liu, G.; Smith, D. C.; Pili, R.; Zwiebel, J.; Scher, H.; Hussain, M.
Cancer (2009)

Fulltext@MSK | Save

A phase I study of oral panobinostat (LBH589) alone and in combination with docetaxel (Doc) and prednisone in castration-resistant prostate cancer (CRPC)

Meeting Abstract

Rathkopf, D. E.; Wong, B. Y.; Ross, R. W.; George, D. J.; Picus, J.; Tanaka, E.; Chen, Y.; Atadja, P.; Yang, W.; Culver, K. W.; more...
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Phase I study of docetaxel (Tax) and (153)Sm repetitively administered for castrate metastatic prostate cancer (CMPC)

Meeting Abstract

Morris, M. J.; Pandit-Taskar, N.; Stephenson, R. D.; Hong, C.; Slovin, S. F.; Solit, D.; Rathkopf, D. E.; Carrasquillo, J. A.; Larson, S. M.; Scher, H. I.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Abiraterone acetate and prednisone in patients (Pts) with progressive metastatic castration resistant prostate cancer (CRPC) after failure of docetaxel-based chemotherapy

Meeting Abstract

Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Schwartz, L. H.; Farmer, K.; Anand, A.; Haqq, C.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

A phase I study of oral panobinostat (LBH589) alone and in combination with docetaxel (Doc) and prednisone in castration-resistant prostate cancer (CRPC)

Meeting Abstract

Rathkopf, D. E.; Wong, B. Y.; Ross, R. W.; George, D. J.; Picus, J.; Atadja, P.; Yang, W.; Culver, K. W.; Woo, M. M.; Scher, H. I.
Annals of Oncology (2008)

Fulltext@MSK | Save

Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer

Journal Article

Rathkopf, D.; Carducci, M. A.; Morris, M. J.; Slovin, S. F.; Eisenberger, M. A.; Pili, R.; Denmeade, S. R.; Kelsen, M.; Curley, T.; Halter, M.; more...
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

A phase II trial of rapid androgen cycling and docetaxel (Doc) in prostate cancer patients with a rising prostate-specific antigen (PSA) in the noncastrate state

Meeting Abstract

Rathkopf, D. E.; Carducci, M. A.; Slovin, S.; Morris, M. J.; Kelsen, M.; Pili, R.; Denmeade, S. R.; Eisenberger, M.; Scher, H. I.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Phase I study of docetaxel and (153)Sm repetitively administered for castrate metastatic prostate cancer (CMPC)

Meeting Abstract

Morris, M. J.; Pandit-Taskar, N.; Amodio, A. J.; Gignac, G. A.; Flatts, E.; Slovin, S.; Solit, D.; Rathkopf, D.; Larson, S.; Scher, H. I.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Suberoylanilide hydroxamic acid (vorinostat) post chemotherapy in hormone refractory prostate cancer (HRPC) patients (pts): A phase II trial by the Prostate Cancer Clinical Trials Consortium (NCI 6862)

Meeting Abstract

Hussain, M.; Dunn, R.; Rathkopf, D.; Stadler, W.; Wilding, G.; Smith, D. C.; Bradley, D.; Cooney, K. A.; Zweibel, J.; Scher, H.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

PCK3145, a novel multitargeted signalling agent for the treatment of castrate metastatic prostate cancer (CMPC)

Meeting Abstract

Slovin, S. F.; Dulude, H.; Pancha, C.; Czanny, M.; Curley, T.; Morris, M.; Rathkopf, D.; Schwartz, L.; Heller, G.; Scher, H. I.
Molecular Cancer Therapeutics (2007)

Fulltext@MSK | Save